ArticleBreast cancer research : BCR2022
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.
Zexuan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it